Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21437770rdf:typepubmed:Citationlld:pubmed
pubmed-article:21437770lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:21437770lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:21437770lifeskim:mentionsumls-concept:C0242184lld:lifeskim
pubmed-article:21437770lifeskim:mentionsumls-concept:C0439148lld:lifeskim
pubmed-article:21437770lifeskim:mentionsumls-concept:C0016315lld:lifeskim
pubmed-article:21437770lifeskim:mentionsumls-concept:C0699914lld:lifeskim
pubmed-article:21437770lifeskim:mentionsumls-concept:C0449851lld:lifeskim
pubmed-article:21437770lifeskim:mentionsumls-concept:C1561604lld:lifeskim
pubmed-article:21437770lifeskim:mentionsumls-concept:C0449560lld:lifeskim
pubmed-article:21437770lifeskim:mentionsumls-concept:C0243163lld:lifeskim
pubmed-article:21437770lifeskim:mentionsumls-concept:C0392762lld:lifeskim
pubmed-article:21437770lifeskim:mentionsumls-concept:C1999230lld:lifeskim
pubmed-article:21437770pubmed:issue4lld:pubmed
pubmed-article:21437770pubmed:dateCreated2011-4-6lld:pubmed
pubmed-article:21437770pubmed:abstractTextHypoxia is a characteristic of tumors, is known to increase aggressiveness, and causes treatment resistance. Traditional classification suggests two types of hypoxia: chronic and acute. Acute hypoxia is mostly caused by transient disruptions in perfusion, while chronic hypoxia is caused by diffusion limitations. This classification may be insufficient in terms of pathogenetic and pathophysiological mechanisms. Therefore, we quantified hypoxia subtypes in tumors based on (immuno-)fluorescent marker distribution patterns in microcirculatory supply units (MCSUs).lld:pubmed
pubmed-article:21437770pubmed:languageenglld:pubmed
pubmed-article:21437770pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21437770pubmed:citationSubsetIMlld:pubmed
pubmed-article:21437770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21437770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21437770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21437770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21437770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21437770pubmed:statusMEDLINElld:pubmed
pubmed-article:21437770pubmed:monthAprlld:pubmed
pubmed-article:21437770pubmed:issn1439-099Xlld:pubmed
pubmed-article:21437770pubmed:authorpubmed-author:VaupelPeterPlld:pubmed
pubmed-article:21437770pubmed:authorpubmed-author:AstnerSabrina...lld:pubmed
pubmed-article:21437770pubmed:authorpubmed-author:BayerChristin...lld:pubmed
pubmed-article:21437770pubmed:authorpubmed-author:ShiKuangyuKlld:pubmed
pubmed-article:21437770pubmed:authorpubmed-author:MafteiConstan...lld:pubmed
pubmed-article:21437770pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21437770pubmed:volume187lld:pubmed
pubmed-article:21437770pubmed:ownerNLMlld:pubmed
pubmed-article:21437770pubmed:authorsCompleteYlld:pubmed
pubmed-article:21437770pubmed:pagination260-6lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:meshHeadingpubmed-meshheading:21437770...lld:pubmed
pubmed-article:21437770pubmed:year2011lld:pubmed
pubmed-article:21437770pubmed:articleTitleQuantitative assessment of hypoxia subtypes in microcirculatory supply units of malignant tumors using (immuno-)fluorescence techniques.lld:pubmed
pubmed-article:21437770pubmed:affiliationDepartment of Radiotherapy and Radiation Oncology, Technical University of Munich, Munich, Germany.lld:pubmed
pubmed-article:21437770pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21437770pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed